The ASA-BIOP Nonclinical Biostatistics Working Group (NCBWG) endorsed the creation of a new workstream co-chaired by Phillip Yates of Pfizer Inc. and Katja Remlinger of GSK. The goal of the workstream is to provide information, insight, and networking opportunities for students interested in careers in the nonclinical area and offer a forum for young professionals to more actively engage in ASA-BIOP activities.
In addition to supporting the Nonclinical Biostatistics Conference, we are interested in pairing industry veterans with nearby academic partners. Contact Yates or Remlinger or visit the NCBWG website for more information or to volunteer.
Leave a Reply